Aptar Pharma Completes First Phase of Global Expansion Program
Aptar Pharma has delivered the first phase of its previously announced expansion program of approximately $180 million to meet growing customer capacity needs.
Stay updated with breaking news from Aptar Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Aptar Pharma has delivered the first phase of its previously announced expansion program of approximately $180 million to meet growing customer capacity needs.
Aptar Pharma has delivered the first phase of its previously announced expansion program of approximately $180 million to meet growing customer capacity needs.
/PRNewswire/ -- The "Prefilled Syringes Market by Therapeutic Area, Type of Syringe, Type of Material, Type of Molecule, and Key Geographical Regions: Industry...
Lee, MA, Dec. 21, 2022 (GLOBE NEWSWIRE) -- Berkshire Sterile Manufacturing (BSM), a Massachusetts fill finish CMO, and Aptar Pharma, a global leader in...
/PRNewswire/ -- Smart Inhalers Market Size, Share & Trends Analysis Report By Type (Dry Powdered Inhalers, Metered Dose Inhalers), By Indication (Asthma,...